Nature Medicine, Published online: 24 June 2026; doi:10.1038/s41591-026-04532-1 Publisher Correction: Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial